[ORGANIZATION]
Omlyclo
Featured in 2 tracked stories · first seen
Situations
Celltrion biosimilar market expansion
2 clusters · 2 sources · last updated
Latest: Celltrion secures leading market shares for biosimilars in Asia
Celltrion has demonstrated significant financial and market growth driven by its biosimilar portfolio. In its second-quarter 2025 results, the company reported sales of 1.3937 trillion won and an operating profit of 451.
Also covered in
-
Celltrion launches 300mg Omlyclo biosimilar in Europe
[BUSINESS] · 4 sources ·